Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Rhode Island Business Daily.
Press releases published on September 2, 2025
Biohaven Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses. September 12, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN) investors of a class action …
Celebrating Canadian actuarial leadership on the global stage
OTTAWA, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- September 2 marks International Actuaries Day, a moment to recognize the vital contributions actuaries make to society both locally and globally. The Canadian Institute of Actuaries (CIA) is spotlighting …
Hommage au leadership actuariel canadien à l’échelle internationale
OTTAWA, Ontario, 02 sept. 2025 (GLOBE NEWSWIRE) -- Le 2 septembre marque la Journée internationale des actuaires, une occasion de souligner les contributions essentielles que les actuaires apportent à la société, tant sur le plan national qu’international. …
ARMLOGI HOLDING CORP. ANNOUNCES APPOINTMENT OF TWO NEW INDEPENDENT DIRECTORS
WALNUT, CA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse …
PennantPark Floating Rate Capital Ltd. Announces Acquisition of $250 Million Asset Portfolio
MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that it has acquired a portfolio of approximately $250 million of assets, including from TSO Puma SPV, LLC, an affiliate of …
Lifecore Biomedical to Participate in Upcoming Investor Conferences
CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming …
Greif Completes Sale of Containerboard Business
DELAWARE, Ohio, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in performance packaging and services, announced today it has completed the previously announced sale of its containerboard business to Packaging Corporation …
Diginex Announces move into Digital Asset Sustainability Project Verification; Signs Strategic Alliance with BlockRidge
LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, and Valuit Technology Delaware LLC (hereinafter referred to as “BlockRidge”), a leading provider of tokenization …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Berkeley, Calif, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an …
STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
Lyell Immunopharma Announces Participation in September Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation CAR T-cell therapies for patients with cancer, …
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference. The …
Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief …
LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President …
Alto Ingredients, Inc. to Present in the 27th Annual H.C. Wainwright Global Investment Conference
PEKIN, Ill., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the H.C. …
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “ …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an …